MarketMindUS Markets Closed
AI-assisted · Not financial adviceNot adviceAI-assisted · Not financial advice.
CAPR shares drop after FDA concerns
Target: $50 avg
10 Buy · 0 Hold · 0 Sell
Based on curated news sources (not retail comments)
Over the last 7 days: CAPR faces significant FDA concerns that overshadow bullish options trading.
Options positioning: Bullish — More betting on downside (2.3× more put than call volume today). Unusual bets on $10 upside — 19× normal activity. analysts: 10 buy vs 0 sell.